Denali Therapeutics Market Sentiment

Denali Therapeutics Inc

DNLINASDAQ

Trade with Public

$18.73

-0.20-1.03%

Dern. MÀJ: Oct 21, 2:22 PM

$18.96

0.030.16%

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Denali Therapeutics Market Sentiment - Benzinga

Denali Therapeutics Market Sentiment

Market sentiment signals for Denali Therapeutics (DNLI): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 10.2% short float

Options Flow▼ 10.79 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

23 analysts

Options Flow (P/C)

10.79

More puts — Bearish

71 calls · 766 puts

Avg Consensus PT

$35

+87.7%

Highest Price Target

$45

+140.2%

Jefferies

Lowest Price Target

$23

+22.8%

Wedbush

Short Interest

10.2%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 25, 2026	B. Riley Securities	Mayank Mamtani—	+86.8%	$30 → $35	Maintained	Buy
Aug 7, 2026	UBS	Michael Yee—	+81.5%	$25 → $34	Maintained	Buy
Jul 23, 2026	Morgan Stanley	Matthew Harrison—	+92.2%	$35 → $36	Maintained	Overweight
Jul 16, 2026	Deutsche Bank	David Hoang—	+86.8%	$31 → $35	Maintained	Buy
Jul 13, 2026	JP Morgan	Jessica Fye—	+54.8%	$29	Reinstates	Overweight
May 26, 2026	Morgan Stanley	Matthew Harrison—	+86.8%	$40 → $35	Maintained	Overweight
May 14, 2026	Morgan Stanley	Matthew Harrison—	+113.5%	$42 → $40	Maintained	Overweight
May 11, 2026	BTIG	Thomas Shrader—	+108.2%	$39 → $39	Maintained	Buy
May 8, 2026	Wedbush	Laura Chico—	+22.8%	$25 → $23	Maintained	Outperform
Apr 22, 2026	Leerink Partners	Marc Goodman—	+86.8%	$40 → $35	Maintained	Outperform
Apr 7, 2026	Baird	Joel Beatty—	+81.5%	$32 → $34	Maintained	Outperform
Mar 26, 2026	Morgan Stanley	Matthew Harrison—	+124.2%	$40 → $42	Maintained	Overweight
Mar 26, 2026	Goldman Sachs	Salveen Richter—	+113.5%	$35 → $40	Maintained	Buy
Mar 26, 2026	Stifel	Paul Mattels—	+118.8%	$34 → $41	Maintained	Buy
Mar 26, 2026	Baird	Joel Beatty—	+70.8%	$29 → $32	Maintained	Outperform
Mar 26, 2026	HC Wainwright & Co.	Andrew S. Fein—	+124.2%	$32 → $42	Maintained	Buy
Mar 25, 2026	BTIG	Thomas Shrader—	+102.8%	$36 → $38	Maintained	Buy
Mar 2, 2026	BTIG	Thomas Shrader—	+92.2%	$32 → $36	Maintained	Buy
Feb 24, 2026	Wolfe Research	Rudy Li—	—	—	Initiate	Peer Perform
Feb 6, 2026	BTIG	Thomas Shrader—	+70.8%	$32 → $32	Maintained	Buy
Jan 7, 2026	UBS	Michael Yee—	+33.4%	$25	Assumes	Buy
Dec 11, 2025	Wedbush	Laura Chico—	+60.1%	$31 → $30	Maintained	Outperform
Dec 5, 2025	Wedbush	Laura Chico—	+65.5%	$30 → $31	Maintained	Outperform
Dec 5, 2025	BTIG	Thomas Shrader—	+70.8%	$32 → $32	Maintained	Buy
Nov 4, 2025	JP Morgan	Jessica Fye—	+38.8%	$24 → $26	Maintained	Overweight